section name header

Information

Author: Raashid Luqmani

Consider vasculitis in the patient with systemic symptoms (e.g. fever, weight loss, malaise) and headache or evidence of organ dysfunction.

Suspected giant-cell arteritis (GCA) (Figure 99.1; see also Chapter 19)Suspected giant-cell arteritis (GCA) (Figure 99.1; see also Chapter 19)
  • Consider in any patient over 50 with new-onset headache (which will usually be of days or a few weeks in duration) or visual symptoms (amaurosis fugax, diplopia and partial or complete loss of vision (Chapter 19)).
  • Associated symptoms include malaise, weight loss, jaw or tongue claudication and scalp tenderness. The temporal artery may be thickened, tender or non-pulsatile, and bruits may be heard over arteries of the head and neck.
  • Check full blood count, C-reactive protein, ESR, biochemical profile and blood glucose. Obtain a chest X-ray (and ultrasonography of the temporal artery, if available).
  • If the clinical picture is suggestive of GCA, and the C-reactive protein is raised, start prednisolone 1 mg/kg per day (max 60 mg per day) with gastric and bone protection.
  • Arrange for a temporal artery biopsy or ultrasound to be done within seven days of starting prednisolone.
  • Seek advice from a rheumatologist or vasculitis specialist on management and follow-up.
New presentation of suspected systemic vasculitis (Figure 99.2)New presentation of suspected systemic vasculitis (Figure 99.2)

Principles of Management

  • Assess for other causes of the clinical presentation (e.g. infection; see Table 99.3).
  • Look for evidence of organ-threatening or life-threatening disease, which may require admission to ICU or HDU for supportive care. Close observation and repeated re-examination of the patient with suspected systemic vasculitis is very important, as the clinical features may rapidly evolve.
  • Contact a specialist in vasculitis for advice on management.
  • Do not start corticosteroid or other anti-inflammatory treatment without advice from a specialist in vasculitis, as this may reduce the diagnostic yield of biopsy, and prevent the patient's inclusion in clinical trials of therapy.
  • Biopsy of the affected organ is the most important test to organize; imaging may be an adequate substitute for some diseases (e.g. large-vessel vasculitis).

Further Reading

Buttgereit F, Dejaco C, Matteson EL, Dasgupta B (2016) Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA 315, 24422458. DOI: 10.1001/jama.2016.5444.

Luqmani RA (2014) Vasculitis: an update. British Journal of Hospital Medicine 75, 432439.

Vasculitis UK website: www.vasculitis.org.uk.

Vasculitis UK. Route map for vasculitis 2014. http://www.vasculitis.org.uk/content/downloads/r-m-july-2014.pdf.